Skip to main content

Infusion Pump Market Size 2021 | Is Predicted to Reach USD 16.09 Billion by 2026, Exhibiting a CAGR of 7.1%

Pune, India, April 19, 2021 (GLOBE NEWSWIRE) — Global Infusion Pump Market 2021 size is predicted to reach USD 16.09 billion by 2026, exhibiting a CAGR of 7.1% during the forecast period. The increasing prevalence of chronic diseases will spur demand for infusion pumps in the forthcoming years. Moreover, the growing advancements in drug delivery systems will boost the infusion pumps industry trends during the forecast period. The increasing adoption of advanced treatment techniques will have a positive impact on the infusion pump market growth in the foreseeable future.

The market size stood at USD 9.28 billion in 2018. The global Infusion Pump Market report focuses and elaborates the definition, types, applications and major players in detail. Deep analysis about market status, competition pattern, enterprise, advantages and disadvantages of enterprise products, industry development trends, regional industrial layout characteristics and macroeconomic policies, industrial policy has also been studied and provided within the synopsis.

The Report Lists the Main Companies in the Infusion Pump Market:

  • Medtronic
  • BD
  • Baxter
  • Insulet Corporation
  • icumedical
  • B. Braun Melsungen AG
  • Smiths Medical (Smiths Group plc.)
  • Fresenius Kabi AG
  • Terumo Corporation

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/infusion-pump-market-102554

Regional Analysis

Favorable Reimbursement Policies to Boost Growth in North America

The market in North America stood at USD 3.41 billion in 2018. The growth in region is attributed to higher diagnosis and treatment rates for diabetes coupled with high adoption of ambulatory infusion pumps. Moreover, favorable reimbursement policies will aid growth in the region. Europe is predicted to witness steady growth during the forecast period owing to the prevalence of chronic diseases in the region.

Asia Pacific is predicted to grow significantly during the forecast period owing to the growing healthcare infrastructure, growing GDP, increasing per capita disposable income. The increasing awareness about the available advanced therapies will further influence growth in the region. The market in Latin America and the Middle East & Africa is at nascent stage. Nonetheless, focus of leading players towards market presence will augment growth in the regions.

Out research methodology is robust and includes data triangulation based on bottom-up and top-down approaches. We validated the approximate market number with the help of primary research. Secondary research was conducted to find out detailed information about mergers & acquisitions, collaborations, joint ventures, and agreements. At the same time, we have derived significant information about the market dynamics associated with growth drivers, trends, and obstacles.

Click here to get the short-term and long-term impact of COVID-19 on this Market.
Please visit: https://www.fortunebusinessinsights.com/infusion-pump-market-102554

Market Driver:

Growing Cases of Cancer and Diabetes to Aid Market Expansion

The increasing incidence of cancer among patients will spur opportunities for the Infusion Pump Market during the forecast period. According to the World Health Organization (WHO), in 2018, cancer was estimated to be the second most prominent cause of death globally and is responsible for about 9.6 million deaths. Cancer patients require chemotherapy which is to be delivered to the patients in a continuous manner which can be achieved by using the infusion pumps. Moreover, the knowledge about the advantages of infusion pumps such as the ability to administer fluids in small dosage and at accurate programmed rates will promote the infusion pumps industry revenue.

Furthermore, the growing cases of diabetes will fuel demand for infusion pumps, which in turn, will bolster healthy growth of the market. according to the International Diabetes Federation (IDF), in 2019, the prevalence of diabetes was estimated to be around 463 million cases worldwide. For instance, the insulin infusion pumps are used to administer drugs to maintain blood-sugar level in the bloodstream. In addition, infusion pumps are preferred in the management of type 1 diabetes.

Quick Buy – Infusion Pump Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/102554

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving.

Overall, almost every sector is anticipated to be impacted by the pandemic. We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/infusion-pump-market-102554

Table of Content:

  • Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Key Insights
    • Prevalence of Chronic Disorders (Diabetes, Cancer, Neurological Disorders etc.)
    • Key Industry Developments – Mergers, Acquisitions, Partnerships & New Product Launch
    • Technological Advancements in Infusion Pump
    • Regulatory Scenario by Key Countries/Region
    • Key Industry Trends
  • Global Infusion Pump Market Analysis, Insights and Forecast, 2015-2026
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Type
      • Volumetric Pumps
      • Syringe Pumps
      • Elastomeric Pumps
      • Insulin Pumps
      • Enteral Pumps
      • Implantable Pumps
      • Patient Control Analgesia (PCA) Pumps
    • Market Analysis, Insights and Forecast – By Application
      • Diabetes
      • Ambulatory Care Settings
      • Pain Management
      • Others

Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/infusion-pump-market-102554

Have a Look at Related Reports:

Medical Imaging Market Size, Share & COVID-19 Impact Analysis, Type (Magnetic Resonance Imaging, Computed Tomography, X-ray, Ultrasound and Molecular Imaging), By Application (Cardiology, Neurology, Orthopedics, Gynecology, Oncology and Others), By End User (Hospitals, Specialty Clinics, Diagnostic Imaging Centers, and Others), and Regional Forecast, 2020-2027

mHealth Apps Market Size, Share & Industry Analysis, By App Type (Disease & Treatment Management, Wellness Management, Others), By Application (Monitoring Services, Fitness Solutions, Diagnostic Services, Treatment Services, Others), By Operating System Type (Google Play Store, Apple App Store, Others) and Regional Forecast, 2019-2026

Pain Management Devices Market Size, Share and Industry Analysis By Product Type (Electrical Stimulation Devices, RF Ablation Devices, Neuromodulation Devices, Infusion Pumps), By Application (Musculoskeletal, Brain, Cancer, Neuropathy, Others), By End User (Physiotherapy Centers, Hospitals and Clinics, Others) and Regional Forecast, 2019 – 2026

Diabetic Ulcer Treatment Market Size, Share and Covid-19 Impact Analysis, By Ulcer Type (Foot Ulcer (Neuropathic Ulcer, Ischemic Ulcer, and Neuro-ischemic Ulcer), Mouth Ulcer, and Others), By Treatment Type (Wound-care Dressings, Wound-care Devices, Active Therapies, and Others), By End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Homecare Settings), and Regional Forecast, 2020-2027

Reading Glasses Market Size, Share & Industry Analysis, By Age Group (Less than 18 years, 18-64 years, and 65 years and above), By Type (Prescription Reading Glasses and OTC Reading Glasses), By Distribution Channel (Retail Stores, Online Sales Channels, Ophthalmol-ogy Clinics), and Regional Forecast, 2019-2026

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs

Press Release: https://www.fortunebusinessinsights.com/press-release/infusion-pump-market-9714

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.